Dr. Klaus-dieter Langner
Chief Scientific Officer
Pharmaceuticals
Grunenthal Group
Switzerland
Biography
Dr. Klaus-Dieter Langner, Ph.D. has been the Chief Scientific Officer at Grünenthal GmbH since July 2013 and serves as its Member of Corporate Executive Board. Dr. Langner served as an Executive Vice President and Chief Operating Officer of Grünenthal Innovation of Grünenthal GmbH since January 2011, Dr. Langner started his career at Behring Werke AG in Marburg as a Research Scientist followed by various management positions with increasing responsibilities. In January 1998 Dr. Langner moved to Grünenthal GmbH as Head of Preclinical Development. In 2000 he became responsible for Global Preclinical R&D with the functions Drug Discovery, Nonclinical Development, Technical Drug Development and the NTE Unit. Dr. Langner serves as Chairman of the Supervisory Board of BiSo AG. He serves as a Member of Supervisory Board at Spinal Cord Therapeutics GmbH. He studied and received the PhD. from the University of Cologne in 1986.
Research Interest
Business
